Endoplasmic Reticulum: Keeping in shape
The endoplasmic reticulum is the largest single structure in eukaryotic cells. It consists of a range of interconnected shapes, including sheets and tubules, and comprises a lumen enclosed by a membrane that is continuous with the membrane that surrounds the nucleus of the cell (Figure 1). The structure and dynamic nature of the endoplasmic reticulum allow it to be involved in many processes in cells: these processes include protein production and degradation, cell signaling, and the synthesis and distribution of lipids and fat molecules. Form follows function, and understanding how the distinct shapes of the endoplasmic reticulum are regulated and maintained is currently an area of intense interest in cell biology (Goyal and Blackstone, 2013; Westrate et al., 2015).
Over the past decade, several proteins that shape the endoplasmic reticulum have been identified. In many cases, these proteins are evolutionarily conserved across eukaryotes, from yeast to mammalian cells. Membrane proteins of the reticulon and REEP families can generate curves in membranes and act to maintain the tubules (Voeltz et al., 2006). Atlastin proteins mediate the tethering and fusion of tubules to one other to form three-way junctions (Hu et al., 2009; Orso et al., 2009), which appear to be stabilized by a membrane protein called lunapark (Shemesh et al., 2014; Chen et al., 2015). Several other proteins help the endoplasmic reticulum to maintain contact with the cell membrane, other cell compartments and the cytoskeleton. Increasingly, studies have revealed dynamic changes in the shape of the endoplasmic reticulum in processes such as cell division and during electrical activity in neurons (Goyal and Blackstone, 2013; Phillips and Voeltz, 2016).
Proteins involved in shaping the endoplasmic reticulum have mostly been studied individually, even though they are known to interact with one another. Now, in eLife, Tom Rapoport and co-workers at Harvard Medical School – including Songyu Wang, Hanna Tukachinsky and Fabian Romano – report on how three key proteins work together to shape and maintain the endoplasmic reticulum (Wang et al., 2016).
Wang et al. performed CRISPR/Cas9 gene knock outs and stable gene transfections in mammalian cells and also investigated egg extracts from the frog Xenopus, which can form an endoplasmic reticulum network in vitro that is strikingly similar to that seen in intact cells. They found that in addition to being required for the formation of three-way junctions, atlastins are also necessary to maintain such junctions. Wang et al. further report on the interplay among the proteins that are involved in shaping the endoplasmic reticulum. For instance, lunapark is not required for three-way junctions to form, but its depletion appears to cause a loss of tubule junctions and an increase in the number of sheet-like structures.
Another remarkable finding is that the endoplasmic reticulum network fragments if atlastin is inhibited (see also Orso et al., 2009), or if the reticulon proteins are overexpressed. This indicates that the network can spontaneously disassemble in some circumstances and may explain why no proteins specifically involved in the splitting of tubules have ever been identified. Although the endoplasmic reticulum is generally thought to be continuous, previous studies have shown that it can split up in certain situations, for example during the fertilization of starfish eggs or during excessive electrical activity in neurons (Goyal and Blackstone, 2013). A future challenge will be to find out how and why cells might fragment their endoplasmic reticulum.
Finally, Wang et al. propose a compelling mechanism for how lunapark is regulated by phosphorylation during cell division. Modifying lunapark to mimic phosphorylated lunapark caused it to disappear from three-way junctions. This result, coupled with a recent study showing that lunapark is a component of a ubiquitin ligase complex at three-way junctions (Zhao et al., 2016), will probably lead to additional studies into how structural modifications regulate these proteins to control the shape of the endoplasmic reticulum.
We have likely just scratched the surface of how the endoplasmic reticulum is shaped, and additional proteins and regulatory mechanisms will surely be uncovered. Investigating the dynamic interactions of the endoplasmic reticulum with other cell compartments and the plasma membrane seems a particularly exciting area. Furthermore, numerous endoplasmic reticulum shaping proteins are mutated in inherited neurological disorders, particularly the hereditary spastic paraplegias (Blackstone, 2012). Future studies will benefit from emerging new super-resolution microscopy tools, improving our understanding of how the endoplasmic reticulum is dynamically shaped in health and disease.
References
-
Cellular pathways of hereditary spastic paraplegiaAnnual Review of Neuroscience 35:25–47.https://doi.org/10.1146/annurev-neuro-062111-150400
-
Untangling the web: mechanisms underlying ER network formationBiochimica Et Biophysica Acta 1833:2492–2498.https://doi.org/10.1016/j.bbamcr.2013.04.009
-
Structure and function of ER membrane contact sites with other organellesNature Reviews Molecular Cell Biology 17:69–82.https://doi.org/10.1038/nrm.2015.8
-
Form follows function: the importance of endoplasmic reticulum shapeAnnual Review of Biochemistry 84:791–811.https://doi.org/10.1146/annurev-biochem-072711-163501
-
Lunapark is a component of a ubiquitin ligase complex localized to the endoplasmic reticulum three-way junctionsJournal of Biological Chemistry 291:18252–18262.https://doi.org/10.1074/jbc.M116.737783
Article and author information
Author details
Publication history
Copyright
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Metrics
-
- 17,634
- views
-
- 485
- downloads
-
- 7
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
Proliferating animal cells maintain a stable size distribution over generations despite fluctuations in cell growth and division size. Previously, we showed that cell size control involves both cell size checkpoints, which delay cell cycle progression in small cells, and size-dependent regulation of mass accumulation rates (Ginzberg et al., 2018). While we previously identified the p38 MAPK pathway as a key regulator of the mammalian cell size checkpoint (S. Liu et al., 2018), the mechanism of size-dependent growth rate regulation has remained elusive. Here, we quantified global rates of protein synthesis and degradation in cells of varying sizes, both under unperturbed conditions and in response to perturbations that trigger size-dependent compensatory growth slowdown. We found that protein synthesis rates scale proportionally with cell size across cell cycle stages and experimental conditions. In contrast, oversized cells that undergo compensatory growth slowdown exhibit a superlinear increase in proteasome-mediated protein degradation, with accelerated protein turnover per unit mass, suggesting activation of the proteasomal degradation pathway. Both nascent and long-lived proteins contribute to the elevated protein degradation during compensatory growth slowdown, with long-lived proteins playing a crucial role at the G1/S transition. Notably, large G1/S cells exhibit particularly high efficiency in protein degradation, surpassing that of similarly sized or larger cells in S and G2, coinciding with the timing of the most stringent size control in animal cells. These results collectively suggest that oversized cells reduce their growth efficiency by activating global proteasome-mediated protein degradation to promote cell size homeostasis.
-
- Cell Biology
- Physics of Living Systems
The regulation of cell physiology depends largely upon interactions of functionally distinct proteins and cellular components. These interactions may be transient or long-lived, but often affect protein motion. Measurement of protein dynamics within a cellular environment, particularly while perturbing protein function with small molecules, may enable dissection of key interactions and facilitate drug discovery; however, current approaches are limited by throughput with respect to data acquisition and analysis. As a result, studies using super-resolution imaging are typically drawing conclusions from tens of cells and a few experimental conditions tested. We addressed these limitations by developing a high-throughput single-molecule tracking (htSMT) platform for pharmacologic dissection of protein dynamics in living cells at an unprecedented scale (capable of imaging >106 cells/day and screening >104 compounds). We applied htSMT to measure the cellular dynamics of fluorescently tagged estrogen receptor (ER) and screened a diverse library to identify small molecules that perturbed ER function in real time. With this one experimental modality, we determined the potency, pathway selectivity, target engagement, and mechanism of action for identified hits. Kinetic htSMT experiments were capable of distinguishing between on-target and on-pathway modulators of ER signaling. Integrated pathway analysis recapitulated the network of known ER interaction partners and suggested potentially novel, kinase-mediated regulatory mechanisms. The sensitivity of htSMT revealed a new correlation between ER dynamics and the ability of ER antagonists to suppress cancer cell growth. Therefore, measuring protein motion at scale is a powerful method to investigate dynamic interactions among proteins and may facilitate the identification and characterization of novel therapeutics.